Cell 'Under Review': What Each Status Means and When to Expect a Decision

In our pre-submission review work, what we see during the Cell review process is that the manuscripts which survive triage already carried a complete, conceptually significant story, and the revisions that succeed deliver the specific mechanistic experiments reviewers request rather than peripheral additions. Most papers that stall at Cell do so at the editorial pre-screen, before review, on conceptual advance and completeness. While under review, treat the reviewers' key mechanistic asks as the priority; that is what determines a Cell outcome.

Cell operates the Cell Press consulting editor model with full-time professional editors. Cell's editors are full-time professionals, not academic editors fitting journal work around their own research. The consulting editor reads the entire paper and evaluates top-tier life-sciences mechanism, broad biology significance, and Cell Press family routing.

Cell is positioned as the Cell Press flagship for top-tier mechanism-depth life-sciences, distinct from the broader-biology scope of Cell Reports or the clinical-translation focus of Cell Reports Medicine.

Cell Press editorial culture at Cell is decisive: roughly 80 to 85 percent of submissions are rejected at the consulting editor stage within 7 to 10 business days. Papers that pass the consulting editor stage have cleared the steepest filter at Cell Press.

Before the paper reaches external reviewers, a Cell Press consulting editor at Cell evaluates whether the top-tier life-sciences mechanism warrants Cell's selective editorial slots. Days 1 to 3 involve technical screening, where the Cell Press editorial office checks data availability statements and file completeness. Incomplete submissions get returned without entering triage. Roughly 80 to 85 percent of submissions are rejected at the desk-screen stage within 7 to 10 business days.

A desk rejection most often means the consulting editor concluded that the work would fit better at a sister Cell Press title (Molecular Cell for mechanism, Cell Reports for broader scope, Cell Reports Medicine for clinical-translation, iScience for open-access) or that the broad-significance bar is not met.

• Day 0 to 3, administrative processing: The Cell Press editorial office confirms files are complete: manuscript with figures embedded, supplementary information separate, reporting checklists where applicable (ARRIVE for animal work, MIQE for quantitative PCR, CONSORT for any clinical-trial component), cover letter directed to the editor, conflict-of-interest declarations, ethics-statement documentation, IRB approvals, and data-availability statement.
• Days 3 to 10, consulting editor desk screen (7 to 10 business day target): The consulting editor reads the paper and evaluates top-tier life-sciences mechanism, broad biology significance, and Cell Press family routing.
• Days 5 to 10, internal editor discussion (parallel for ambiguous cases): In parallel with the consulting editor's primary read, ambiguous-fit papers are discussed across the Cell Press editorial team where peer consulting editors at sister Cell Press titles weigh in on whether the paper would fit better at Cell, Molecular Cell, or Cell Reports. This editorial-team discussion runs alongside the desk-screen and adds 2 to 4 days to the timeline that is invisible to the author in the portal.
• Days 10 to 28, external reviewer recruitment: Cell Press consulting editors at Cell typically invite 2 to 3 external reviewers. The recruitment window can take 7 to 14 days because reviewers with topic-matched top-tier life-sciences mechanism expertise are scarce. Cell Press journals consider 10 days to be sufficient time to complete a review.
• Days 14 to 84, active peer review (10-day reviewer target): Once reviewers agree to review, the typical Cell peer-review cycle lasts 2 to 6 weeks per reviewer, contributing to the 2.8-month median first-decision. Reviewers are asked to evaluate top-tier life-sciences mechanism, broad biology significance, and reproducibility.
• Day 84 onward, editorial synthesis and decision: After reports return, the consulting editor synthesizes them. The 2.8-month first-decision median applies to papers that reach external peer review.

• Rejection within 1 to 3 days: Administrative issue or immediate scope mismatch.

• Rejection within 7 to 10 business days: Consulting editor desk rejection per the median.

• Still Under Review after 3 weeks: Strong signal. Paper passed the Cell Press filter.

• Still Under Review after 12 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry to celleditor@cell.com is appropriate.

• Status changes to "Decision Pending": Reports are in; expect a decision within 2 to 3 weeks.

This is the most common anxiety we hear from Cell authors during the active editorial window. The honest answer: no, 8 weeks at Under Review puts you mid-cycle in Cell's 2.8-month first-decision distribution. Reports may already be in editorial synthesis with the consulting editor preparing the recommendation letter.

Most reviewer-driven delays come from reviewer-recruitment timing rather than slow reviews because Cell Press recruits topic-matched top-tier life-sciences reviewers who are scarce. If the portal still says Under Review at the 12-week mark, the most likely explanation is that one of the assigned reviewers asked for an extension and the consulting editor granted it. This is normal practice at Cell Press.

What you should NOT do during the 8-to-12-week window is email the editorial office.

• Do not email the editorial office during the first 6 weeks unless an urgent ethics issue surfaces.

• Do not submit the paper anywhere else while it is Under Review at Cell. Cell Press has explicit prohibitions on dual submission.

• Prepare a point-by-point response template for likely reviewer concerns: top-tier life-sciences mechanism, broad biology significance, reproducibility (especially STAR Methods compliance).

• If you have related work submitted elsewhere or recently published, prepare disclosure language for when revisions are requested.

• Read recent Cell papers in your subfield to calibrate the current editorial bar.

If your Cell paper is rejected after review, the natural cascade depends on what the reviewers and consulting editor cited:

Molecular Cell is the natural Cell Press cascade for mechanism-depth molecular-biology papers. Cell Press supports manuscript-transfer via the portable peer-review system, preserving reviewer reports.

Cell Reports is the Cell Press cascade for broader life-sciences work where the broad-significance bar of Cell is not met but the scientific rigor is high.

Cell Reports Medicine is the Cell Press cascade for clinical-translational papers.

iScience is the Cell Press open-access cascade for technically rigorous papers where the open-access publishing model fits.

Nature is the external cascade for top-tier broad-significance life-sciences work. Springer Nature operates independently from Cell Press; reports do not transfer.

Science is the external cascade for top-tier general-science work. AAAS operates independently from Cell Press; reports do not transfer.

Cell Press asks reviewers to evaluate four things specifically. The table below maps each to actionable preparation.

Across Cell-targeted manuscripts, three named patterns generate the most consistent reviewer concerns and the most common reasons an "Under Review" status later turns into major revision, transfer, or rejection. Cell editors first ask whether the paper is a complete mechanism story with broad biology significance. Reviewers then test whether STAR Methods, figures, controls, and data availability make that story reproducible.

Narrow-mechanism framing is flagged at the editorial screen. When the title, abstract, first figure, and introduction frame the work around one pathway, model, or disease niche without broader biology significance, Cell editors often treat the manuscript as a better fit for Molecular Cell, Developmental Cell, Cell Reports, or another Cell Press title. The strongest Cell manuscripts make the mechanism feel complete and field-moving by the end of Figure 1.

If your first screen does not make that case, run a Check whether your Cell mechanism framing is strong enough → while the paper is still active.

STAR Methods documentation gaps surface as reviewer requests. When STAR Methods documentation is thin, especially for AAV constructs, custom analysis code, single-cell sequencing pipelines, imaging analysis, reagent provenance, or cell-line authentication, Cell reviewers consistently request expanded Methods and Key Resources detail before issuing a final recommendation. The strongest revisions add reagent catalog numbers, software versions, parameter settings, repository links, and exact exclusion criteria.

If your STAR Methods package is still compressed, use a Check your Cell STAR Methods package → before reviewer comments arrive.

Cell Press family cascade offers reveal a significance mismatch. When the consulting editor concludes the work is rigorous but below Cell's breadth bar, transfer offers to Molecular Cell, Cell Reports, Cell Reports Medicine, or iScience are common. In the manuscripts we review, this pattern usually appears when the figures are technically strong but the cover letter, summary, and discussion do not explain why the mechanism changes how a broad life-sciences reader thinks.

The right response is to prepare a transfer-ready cover letter and reviewer-response file that preserve review momentum. If you need that route mapped now, run a Check whether your Cell Press transfer route is ready →.

This page helps Cell authors decide what to prepare while the portal is quiet: a stronger response, a cleaner STAR Methods package, or a realistic Cell Press transfer plan. It tells you what Cell editors look for while the manuscript is being routed or reviewed. The review tells you whether your paper passes that check before the decision arrives.

Manusights review data from Cell and adjacent Cell Press manuscripts shows these failure patterns repeatedly; in practice, we see STAR Methods and mechanism-closure issues drive more revision work than portal labels imply. 60-day money-back guarantee. Your manuscript is not used for model training, and access is limited to the review workflow.

Sources behind this page: Cell's author instructions, which give the 10-day median from submission to first decision; SciRev community data (8 days to immediate rejection and a 2.8-month first review round, drawn from 9 author reports); the Cell Press rules on transfers and STAR Methods; and what we see in Cell-targeted manuscripts during pre-submission review.

Official guidance covers the visible workflow; the Manusights sections add status-anxiety interpretation from recent Cell-style manuscripts where reviewers focused on mechanism closure, STAR Methods, data availability, and Cell Press fit. Source limitation: Cell Press status fields do not disclose whether a consulting editor is waiting on a specific reviewer, so this page treats timing as a probability signal rather than a private-status claim.

For the Cell Press top-tier life-sciences landscape beyond Cell, see Molecular Cell (mechanism-depth focus, Cell Press portable peer-review transfer), Cell Reports (broader scope, Cell Press transfer-friendly), Cell Reports Medicine (clinical-translation), iScience (Cell Press open-access), and external general-science alternatives (Nature, Science, PNAS).

The choice across these titles depends on whether the central contribution is top-tier mechanism-plus-broad-biology (Cell), mechanism-depth molecular-biology (Molecular Cell), broader life-sciences (Cell Reports), clinical-translational (Cell Reports Medicine), open-access (iScience), or external general-science (Nature, Science, PNAS).

Reviewers at Cell typically draw from one mechanism-focused life-sciences specialist and one broader-biology reviewer. Editors screen and triage manuscripts before any reviewer sees them, and preparing a response template that addresses both perspectives accelerates revision rounds substantially.

Cell Press editorial-process documentation puts the typical full-cycle window for accepted Cell papers at 6 to 10 weeks from submission to first decision when a paper goes to peer review, with desk rejection of about 70 to 80 percent of submissions occurring inside the first 1 to 2 weeks before the paper ever reaches a reviewer.

For a pre-upload check of your manuscript against the Cell top-tier-mechanism-plus-broad-biology bar before submission, our Cell pre-submission diagnostic flags the STAR Methods gaps and narrow-framing weaknesses most likely to surface in reviewer reports.